About RIDGELINE THERAPEUTICS LLC
Ridgeline Therapeutics is a Houston-based biotech company developing safe and effective drugs that selectively target new mechanisms-of-action to treat conditions such as sarcopenia, Type 2 diabetes, obesity, muscular dystrophies, and kidney disease.
Development of first-in-class, highly-selective, and potent small molecule inhibitors of nicotinamide N-methyltransferase (NNMT)Creation of transformative once-daily oral drugs for chronic health problems including musculoskeletal disorders and metabolic diseases
Is this your company?
Claim RIDGELINE THERAPEUTICS LLC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim RIDGELINE THERAPEUTICS LLC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.